title: Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
abstract: BACKGROUND
  Acinetobacter baumannii is a major cause of nosocomial infections in many hospitals and appears to have a propensity for developing multiple antimicrobial resistance rapidly.
  
  
  METHODS
  We report two cases with post-surgical meningitis due to multidrug resistant A. baumannii which were successfully treated with high-dose intravenous meropenem therapy.
  
  
  CONCLUSIONS
  Multidrug resistant Acinetobacter spp. in intensive care units are a growing concern. High-dose meropenem is used in the treatment of these infections.
authors.affiliation: Pamukkale University Hospital, Infectious Diseases and Clinical Microbiology Department, Denzili, Turkey. suzansacar@yahoo.com
authors.forename: Suzan
authors.initials: S
authors.lastname: Saçar
authors.forename: H
authors.initials: H
authors.lastname: Turgut
authors.forename: D Hirçin
authors.initials: DH
authors.lastname: Cenger
authors.forename: E
authors.initials: E
authors.lastname: Coşkun
authors.forename: A
authors.initials: A
authors.lastname: Asan
authors.forename: I
authors.initials: I
authors.lastname: Kaleli
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy*; D040981:Acinetobacter baumannii / Q000187:drug effects*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D013845:Thienamycins / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem